OPTHOptimi Health Corp

$4.67
$0.245
(4.99%)
Today
Closed $4.67
$0.14
(3.00%)
After Hours
Updated: 07:50 PM EDT
Mkt Cap$26.27M
Vol154,239.00
News
all
press releases
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial PR Newswire VANCOUVER, BC, June 10, 2026 The shipment of naturally derived psilocybin, comprising...
PR Newswire
News Placeholder
More News
News Placeholder
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development PR Newswire VANCOUVER, BC, June 8, 2026 Recent US executive order named ibogaine compounds among the psychedelic therapies...
PR Newswire
News Placeholder
Optimi Health (NASDAQ: OPTH) (CSE: OPTI) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update
This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN), a commercial-stage psychedelic pharmaceutical manufacturer, welcomed final recommendations from Australia’s Therapeutic Goods Administration regarding its Authorized Prescriber scheme for psilocybin and MDMA. The updated framework broadens eligible therapy teams, expands treatment settings beyond […]
Investor Brand Network
News Placeholder
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia PR Newswire VANCOUVER, BC, May 29, 2026...
PR Newswire
News Placeholder
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting PR Newswire VANCOUVER, BC, May 20, 2026 Common Shares to Trade on the Nasdaq Capital Market Under...
PR Newswire
<
...
1
>

Advertisement|Remove ads.